Race, breast cancer, and prognosis: Where biology is queen?
Abstract
Even when socioeconomic variables are optimally controlled for, outcomes for black women with breast cancer were still worse than outcomes for white women in this single‐institution study. This highlights the aggressive disease biology present in many black women with breast cancer and serves as a call to action to work harder to discover new and better treatments for this population.Keywords
This publication has 16 references indexed in Scilit:
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationNew England Journal of Medicine, 2017
- Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American WomenEthnicity & Disease, 2017
- Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer SubtypeJournal of Clinical Oncology, 2017
- Patterns and Trends in Age-Specific Black-White Differences in Breast Cancer Incidence and Mortality – United States, 1999–2014MMWR. Morbidity and Mortality Weekly Report, 2016
- Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor RecurrenceJournal of Clinical Oncology, 2015
- Triple-negative breast cancer in African-American women: disparities versus biologyNature Reviews Cancer, 2015
- Medical Mistrust Influences Black Women’s Level of Engagement in BRCA1/2 Genetic Counseling and TestingJournal of the National Medical Association, 2013
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast CancerJournal of Clinical Oncology, 2008
- Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GABreast Cancer Research and Treatment, 2008
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006